Skip to content
Back to AEON

AEON Biopharma, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
1
Purchases
1
Sales
0
Purchase value
$243.46K
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Lynch Timothy P10% owner
4
Filed Aug 21, 2026Period of report Aug 19, 20260000935836-26-000440
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 19, 2026
Class A Common StockF11,150,000$0.2117$243.46K6,500,000Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1975 to $0.2164 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.